PAI-1 has been reported to regulate PD-L1 expression in melanoma cells, as well as promote pro-inflammatory M2 macrophages, mediating immune evasion and the reduced efficacy of anti-PD-L1 therapy in melanoma patients [33,34]. Here, CD274 is linked to melanoma.